Delivery Order SPE2DB22D3401-SPE2DB25FT2LS

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,356.16 to provide ABILIFY MAINTENA ER 400 MG VLS medical products. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 7, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,568.80, is for the supply of ABILIFY MAINTENA ER 400 MG VLS, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of January 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $3,160.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product ABILIFY MAINTENA ER 400 MG VLS, with a performance period ending on May 31, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $2,020.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract is for the delivery of ABILIFY MAINTENA ER 300 MG SYRS, a pharmaceutical product. There is no set-aside...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ABILIFY MAINTENA ER 400 MG SYRS, a specialty pharmaceutical product. The contract has a ceiling value of $23,709.13 and an ultimate completion date of August 5, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated....
This federal contract award, with ID SPE2DB22D6029|SPE2DB25FLUJE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,843.01 firm fixed-price delivery order is for the pharmaceutical product ABILIFY MAINTENA ER 400 MG VLS. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,525.67 Delivery Order contract is for the supply of ABILIFY MAINTENA ER 400 MG VLS, a prescription medication. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Abilify Maintena ER 400 mg vials. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with an ultimate completion date of August 23, 2024 and a ceiling value of $2,471.47. The contract does not have a set-aside designation. Amerisourcebergen, through its Corporate Office Division, has been a long-standing supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,842.17 firm fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 400 MG SYRS, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $23,420.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order with a Firm Fixed Price pricing type. It covers the procurement of ABILIFY MAINTENA ER 400 MG SYRS, a medication for mental health treatment, with an ultimate completion date of December 23, 2024. Amerisourcebergen Drug...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT2LS
    Delivery Order

This federal contract award, valued at $1,735.67, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of ABILIFY MAINTENA ER 300 MG VLS, a pharmaceutical product, to support military healthcare programs.

The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to military healthcare facilities globally. This IDC encompasses critical medical commodities across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any subcontractors. The contract has an ultimate completion date of March 7, 2025.

Generated 6/5/25, 9:42 AM